These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39217772)

  • 1. Silencing ANLN hinders the proliferation, migration, invasion, and angiogenesis of oral squamous cell carcinoma.
    Wu S; Li D; Li L; Zhao J; Zhang H; Zhou X; Wang S; Mo Y; Li P
    Pathol Res Pract; 2024 Oct; 262():155563. PubMed ID: 39217772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncOCMRL1 promotes oral squamous cell carcinoma growth and metastasis via the RRM2/EMT pathway.
    Lu N; Jiang Q; Xu T; Gao Q; Wang Y; Huang Z; Huang Z; Xu X
    J Exp Clin Cancer Res; 2024 Sep; 43(1):267. PubMed ID: 39343925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
    Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
    J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAM122A functions as a tumor suppressor in oral squamous cell carcinoma.
    Zhu H; Huang Y; Chen J
    Exp Cell Res; 2024 Aug; 441(2):114165. PubMed ID: 39009214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway.
    Liu J; Zhang Y; Wu J; Liu X; Li L; Zhang J
    Cancer Genet; 2024 Jun; 284-285():48-57. PubMed ID: 38729078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
    Wang Y; Jiang Y; Chen L
    J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
    Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NR2F2-AS1 inhibits the progression of oral squamous cell carcinoma by mediating the miR-32-5p/SEMA3A axis.
    Qin SY; Li B; Liu JM; Lv QL; Zeng XL
    Kaohsiung J Med Sci; 2024 Oct; 40(10):877-889. PubMed ID: 39177014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data.
    Liu Z; Zhou W; Lin C; Wang X; Zhang X; Zhang Y; Yang R; Chen W; Cao W
    Aging (Albany NY); 2020 Dec; 13(2):2379-2396. PubMed ID: 33318296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 12. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
    Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
    Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
    J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis.
    Ibi H; Takahashi K; Harada H; Watabe T; Podyma-Inoue KA
    Biochem Biophys Res Commun; 2024 Jun; 714():149965. PubMed ID: 38657447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway.
    Zhao Z; Chu W; Zheng Y; Wang C; Yang Y; Xu T; Yang X; Zhang W; Ding X; Li G; Zhang H; Zhou J; Ye J; Wu H; Song X; Wu Y
    Cell Commun Signal; 2021 Dec; 19(1):121. PubMed ID: 34922580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of DSPP and MMP20 Silencing on Adhesion, Metastasis, Angiogenesis, and Epithelial-Mesenchymal Transition Proteins in Oral Squamous Cell Carcinoma Cells.
    Aseervatham J; Ogbureke KUE
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-mediated knock out of ITGB6 in human OSCC cells reduced migration and proliferation ability.
    Geyer M; Geyer F; Reuning U; Klapproth S; Wolff KD; Nieberler M
    Head Face Med; 2024 Jun; 20(1):37. PubMed ID: 38890650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRELP inhibits the progression of oral squamous cell carcinoma via inactivation of the NF-κB pathway.
    Sun X; Chai L; Wang B; Zhou J
    Arch Oral Biol; 2024 Nov; 167():106068. PubMed ID: 39151326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
    Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
    Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX3 plays a tumor suppressor role by inhibiting cell migration, invasion and angiogenesis in oral squamous cell carcinoma.
    Zhou WN; Du YF; Bai J; Song XM; Zheng Y; Yuan H; Zhang W; Zhang ZD; Wu YN
    Oncol Rep; 2017 Oct; 38(4):2378-2386. PubMed ID: 28765934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.